Company Overview and News

 
Why is unemployment refusing to budge in the face of booming jobs growth?

2018-03-18 abc.net.au
The jobs market continues to be one of the more perplexing points of contention in the Australian economy.
Upvote Downvote

 
Australian shares to open flat

2017-05-02 perthnow.com.au
THE Australian market is set to open flat with flat leads from US markets and little in the way of share or economic news to influence investors. At 0700 AEST on Wednesday, the share price futures index was down four points, or 0.07 per cent, at 5,930.
Upvote Downvote

 
Cotton On tops Chadstone office tower

2017-04-07 theage.com.au
Geelong-based retailer Cotton On Group has snapped up the final floor of Chadstone Shopping Centre's new $85 million office tower.
Upvote Downvote

 
Cotton On tops Chadstone office tower

2017-04-07 smh.com.au
Geelong-based retailer Cotton On Group has snapped up the final floor of Chadstone Shopping Centre's new $85 million office tower.
Upvote Downvote

 
Market set to rise after $30bn loss

2017-03-22 perthnow.com.au
AUSTRALIAN shares look set to open comfortably higher the day after almost $30 billion was wiped off the market and the S&P/ASX200 suffered its worst one-day performance since November 9.
Upvote Downvote

 
Bubs Australia gaining traction in organic baby food market

2017-02-17 proactiveinvestors.com.au
Bubs Australia (ASX:BUB) has added key pharmacy wholesalers in Australia to its customer base, giving Bubs immediate access to over 5,000 pharmacies nationwide.
Upvote Downvote

 
Telstra Corporation's (TLSYY) CEO Andy Penn on Q2 2017 Results - Earnings Call Transcript

2017-02-16 seekingalpha
Telstra Corporation Limited (OTCPK:TLSYY) Q2 2017 Results Earnings Conference Call February 15, 2017 5:15 PM ET
Upvote Downvote

 
National Tiles secure a new home

2016-11-13 perthnow.com.au
NATIONAL Tiles has secured a deal for its new Queensland head office at an industrial estate south of Brisbane.
Upvote Downvote

 
Amcal owner Sigma Pharmaceuticals sues former CEO Elmo De Alwis and CFO Mark Smith

2016-10-03 theage.com.au
The owner of Amcal and Guardian pharmacy chains, Sigma Pharmaceuticals, is suing two former disgraced executives over $59.3 million in losses the company allegedly incurred through cooking the company's books.
Upvote Downvote

 
Amcal owner Sigma Pharmaceuticals sues former CEO Elmo De Alwis and CFO Mark Smith

2016-10-03 smh.com.au
The owner of Amcal and Guardian pharmacy chains, Sigma Pharmaceuticals, is suing two former disgraced executives over $59.3 million in losses the company allegedly incurred through cooking the company's books.
Upvote Downvote

 
Sigma Pharmaceuticals Could Be An Excellent Growth Proposition For Long-Term Investors

2016-09-18 seekingalpha
Sigma Pharmaceuticals (OTC:SGMFF) is an Australian based wholesale/retail pharmaceutical company listed on the Australian stock exchange under the code SIP. Sigma's head office is located in Rowville Victoria (Ibis world, 2014).
Upvote Downvote

 
ECB, banks drag ASX down for fourth consecutive week

2016-09-09 theage.com.au
Australian shares closed down for the fourth week in a row after the European Central Bank failed to extend its monetary stimulus program and investors sold big bank stocks. 
Upvote Downvote

 
ECB, banks drag ASX down for fourth consecutive week

2016-09-09 smh.com.au
Australian shares closed down for the fourth week in a row after the European Central Bank failed to extend its monetary stimulus program and investors sold big bank stocks. 
Upvote Downvote

 
Australia shares fall ahead of ECB meeting

2016-09-08 abc.net.au
Australian shares have fallen despite some positive trade data from both Australia and China, as investors exercise caution ahead of a key European Central Bank meeting later in the global day.
Upvote Downvote

 
Miners, banks weigh on ASX as global rally unwinds

2016-09-08 theage.com.au
Australian shares fell sharply on Thursday's open and struggled to find meaningful upward momentum during the session as investors lost their appetite for the big four banks and the miners.
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

23h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...